Gender-Affirming Hormone Therapy for Transgender Men

Clin Obstet Gynecol. 2018 Dec;61(4):687-704. doi: 10.1097/GRF.0000000000000398.

Abstract

There are an estimated 1.4 million transgender adults in the United States, and lack of providers knowledgeable in transgender care is a barrier to health care. Obstetricians and Gynecologists can help increase access in part by becoming competent in gender-affirming hormone therapy. For transgender men, testosterone protocols can be extrapolated from those used for hypogonadal cisgender men. Unfortunately, there are not any high-quality, long-term prospective studies on the effectiveness and safety of different testosterone regimens specifically in transgender men, but the available data suggest that gender-affirming testosterone therapy is safe and effective with proper screening and monitoring.

Publication types

  • Review

MeSH terms

  • Androgens / therapeutic use*
  • Cardiovascular Diseases / epidemiology
  • Clinical Competence
  • Drug Monitoring
  • Female
  • Fertility Preservation
  • Gynecology*
  • Humans
  • Male
  • Obstetrics*
  • Ovariectomy
  • Patient Care Planning
  • Risk
  • Sex Reassignment Procedures
  • Testosterone / therapeutic use*
  • Transgender Persons*

Substances

  • Androgens
  • Testosterone